Szilárd Váncsa

1.7k total citations · 1 hit paper
70 papers, 802 citations indexed

About

Szilárd Váncsa is a scholar working on Surgery, Epidemiology and Infectious Diseases. According to data from OpenAlex, Szilárd Váncsa has authored 70 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 17 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Szilárd Váncsa's work include COVID-19 Clinical Research Studies (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Szilárd Váncsa is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Szilárd Váncsa collaborates with scholars based in Hungary, Romania and Germany. Szilárd Váncsa's co-authors include Bálint Erőss, Péter Hegyi, Zsolt Szakács, Szabolcs Kiss, Gabriella Pár, Fanni Dembrovszky, Nelli Farkas, Lajos Szakó, Péter Hegyi and Noémi Zádori and has published in prestigious journals such as Scientific Reports, American Journal of Obstetrics and Gynecology and Frontiers in Immunology.

In The Last Decade

Szilárd Váncsa

55 papers receiving 788 citations

Hit Papers

Inositol is an effective ... 2023 2026 2024 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    2023 62 citations Szilárd Váncsa, Alex Váradi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Szilárd Váncsa Hungary 16 238 156 151 141 116 70 802
Xiaojing Chen China 16 89 0.4× 159 1.0× 182 1.2× 88 0.6× 53 0.5× 70 755
Rachel E Bridwell United States 15 257 1.1× 192 1.2× 64 0.4× 61 0.4× 193 1.7× 84 832
Andrea Szentesi Hungary 12 179 0.8× 321 2.1× 135 0.9× 221 1.6× 100 0.9× 51 779
Tim Montrief United States 15 157 0.7× 183 1.2× 70 0.5× 40 0.3× 82 0.7× 31 691
Annabelle Stoclin France 15 93 0.4× 187 1.2× 163 1.1× 165 1.2× 55 0.5× 25 639
Prodromos Kanavidis Greece 16 138 0.6× 201 1.3× 68 0.5× 143 1.0× 23 0.2× 38 965
Enrique Esteve‐Valverde Spain 12 167 0.7× 96 0.6× 47 0.3× 22 0.2× 101 0.9× 36 825
D. Á. Galarza-Delgado Mexico 13 88 0.4× 60 0.4× 89 0.6× 50 0.4× 38 0.3× 125 620
Javad Ahmadian Heris Iran 15 75 0.3× 48 0.3× 75 0.5× 75 0.5× 33 0.3× 49 987
Talal Almas Ireland 14 170 0.7× 138 0.9× 90 0.6× 87 0.6× 156 1.3× 120 678

Countries citing papers authored by Szilárd Váncsa

Since Specialization
Citations

This map shows the geographic impact of Szilárd Váncsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szilárd Váncsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szilárd Váncsa more than expected).

Fields of papers citing papers by Szilárd Váncsa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szilárd Váncsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szilárd Váncsa. The network helps show where Szilárd Váncsa may publish in the future.

Co-authorship network of co-authors of Szilárd Váncsa

This figure shows the co-authorship network connecting the top 25 collaborators of Szilárd Váncsa. A scholar is included among the top collaborators of Szilárd Váncsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szilárd Váncsa. Szilárd Váncsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kói, Tamás, Szilárd Váncsa, Lajos V. Kemény, et al.. (2025). Rapid molecular assays versus blood culture for bloodstream infections: a systematic review and meta-analysis. EClinicalMedicine. 79. 103028–103028.
3.
Váncsa, Szilárd, et al.. (2025). Global Trends in Joint Arthroplasty: A Systematic Review and Future Projections. Journal of Clinical Medicine. 14(22). 8214–8214.
4.
Váncsa, Szilárd, László Földvári-Nagy, Péter Hegyi, et al.. (2025). Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials. Gut Microbes. 17(1). 2562341–2562341.
5.
Tóth, Gábor, Shanhe Liu, Shuailin Li, et al.. (2025). Outcomes of Penetrating Keratoplasty and Boston Type 1 Keratoprosthesis in Aniridia-Associated Keratopathy: A Systematic Review and Meta-Analysis. American Journal of Ophthalmology. 282. 405–415.
6.
7.
Váncsa, Szilárd, et al.. (2024). Diagnostic accuracy of ultrasonography in acute lateral ankle ligament injury: A systematic review and meta-analysis. Injury. 55. 111730–111730. 2 indexed citations
8.
9.
Párniczky, Andrea, Péter Hegyi, Szilárd Váncsa, et al.. (2024). Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations. Journal of Crohn s and Colitis. 18(6). 851–863. 6 indexed citations
10.
Veres, Dániel Sándor, Andrea Harnos, Szilárd Váncsa, et al.. (2023). Maternal age is highly associated with non‐chromosomal congenital anomalies: Analysis of a population‐based case‐control database. BJOG An International Journal of Obstetrics & Gynaecology. 130(10). 1217–1225. 6 indexed citations
11.
Váncsa, Szilárd, et al.. (2023). Anisotropy, Anatomical Region, and Additional Variables Influence Young's Modulus of Bone: A Systematic Review and Meta‐Analysis. JBMR Plus. 7(12). e10835–e10835. 5 indexed citations
12.
Hegyi, Péter, Brigitta Teutsch, Tamás Tornai, et al.. (2023). Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies. Frontiers in Medicine. 10. 1114836–1114836. 7 indexed citations
13.
Váncsa, Szilárd, Alex Váradi, Péter Hegyi, et al.. (2023). Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 15(19). 4224–4224. 4 indexed citations
14.
Bunduc, Ștefania, Noémi Gede, Szilárd Váncsa, et al.. (2021). Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta–analysis. Critical Reviews in Oncology/Hematology. 169. 103548–103548. 17 indexed citations
15.
Pár, Alajos, et al.. (2021). Sarcopenia – 2021 Patofiziológia, diagnózis, terápia = Sarcopenia – 2021 Pathophysiology, diagnosis, therapy. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 13 indexed citations
16.
Váncsa, Szilárd, Péter Hegyi, Bálint Erőss, et al.. (2021). Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies. Frontiers in Pharmacology. 12. 619524–619524. 33 indexed citations
17.
Váncsa, Szilárd, Fanni Dembrovszky, Nelli Farkas, et al.. (2021). Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases. Viruses. 13(3). 512–512. 28 indexed citations
18.
Váncsa, Szilárd, Dávid Németh, Péter Hegyi, et al.. (2020). Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 9(9). 2698–2698. 18 indexed citations
19.
Illés, Dóra, Beate Kamlage, Viktor J. Horváth, et al.. (2020). New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial. BMJ Open. 10(11). e037267–e037267. 14 indexed citations
20.
Földi, M., Nelli Farkas, Szabolcs Kiss, et al.. (2020). Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis. Obesity Reviews. 21(10). e13095–e13095. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojing Chen Breakdown of academic impact, for papers by Rachel E Bridwell Breakdown of academic impact, for papers by Andrea Szentesi Breakdown of academic impact, for papers by Tim Montrief Breakdown of academic impact, for papers by Annabelle Stoclin Breakdown of academic impact, for papers by Prodromos Kanavidis Breakdown of academic impact, for papers by Enrique Esteve‐Valverde Breakdown of academic impact, for papers by D. Á. Galarza-Delgado Breakdown of academic impact, for papers by Javad Ahmadian Heris Breakdown of academic impact, for papers by Talal Almas
Rankless by CCL
2026